Suzu Igarashi

1.1k total citations · 1 hit paper
16 papers, 849 citations indexed

About

Suzu Igarashi is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Suzu Igarashi has authored 16 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Suzu Igarashi's work include Immune Cell Function and Interaction (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Herpesvirus Infections and Treatments (3 papers). Suzu Igarashi is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Herpesvirus Infections and Treatments (3 papers). Suzu Igarashi collaborates with scholars based in United States. Suzu Igarashi's co-authors include Li‐Wen Lai, John Sidney, Michael Houghton, Alessandro Sette, Ann L. Erickson, Austin L. Hughes, Denise M. McKinney, Christopher M. Walker, Yoichi Kimura and Felicia Goodrum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Suzu Igarashi

16 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes

2001 321 citations Ann L. Erickson, Yoichi Kimura et al. Immunity profile →

Peers

Suzu Igarashi

EPIDE

IMMUN

HEPAT

VIROL

Kathy Mu United States

Lazaro Lorenzo France

Caroline Martin United Kingdom

Hend Farza France

Bonnie van Wilgenburg United Kingdom

Athalia Klein Israel

Cynthia Brisac United States

Martijn D. B. van de Garde Netherlands

Takashi Hishikawa Japan

Sabrina Imam United States

Kathy Mu United States

Suzu Igarashi

285 ×0.9

EPIDE

186 ×0.6

IMMUN

354 ×1.4

HEPAT

131 ×0.5

55 ×0.5

VIROL

Citations per year, relative to Suzu Igarashi Suzu Igarashi (= 1×) peers Kathy Mu

Countries citing papers authored by Suzu Igarashi

Since Specialization

Citations

This map shows the geographic impact of Suzu Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzu Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzu Igarashi more than expected).

Fields of papers citing papers by Suzu Igarashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzu Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzu Igarashi. The network helps show where Suzu Igarashi may publish in the future.

Co-authorship network of co-authors of Suzu Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Suzu Igarashi. A scholar is included among the top collaborators of Suzu Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzu Igarashi. Suzu Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yun, Tae Jin, Suzu Igarashi, Haoquan Zhao, et al.. (2021). Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells. Science Immunology. 6(58). 40 indexed citations

Hale, Andrew, Donna Collins-McMillen, Erik M. Lenarcic, et al.. (2020). FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation. Proceedings of the National Academy of Sciences. 117(31). 18764–18770. 28 indexed citations

Buehler, Jason, Suzu Igarashi, Michael Rak, et al.. (2019). Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency. PLoS Pathogens. 15(11). e1008037–e1008037. 45 indexed citations

Igarashi, Suzu, et al.. (2018). Virus Control of Trafficking from Sorting Endosomes. mBio. 9(4). 23 indexed citations

Gordon, Claire L., Michelle Miron, Joseph J.C. Thome, et al.. (2017). Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection. The Journal of Experimental Medicine. 214(3). 651–667. 101 indexed citations

Mercado-Pimentel, Melania E., et al.. (2016). The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation.. PubMed. 3(1). 9 indexed citations

Mercado-Pimentel, Melania E., et al.. (2016). Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe. Otology & Neurotology. 38(1). 139–146. 7 indexed citations

Igarashi, Suzu, et al.. (2015). Zebrafish swimming behavior as a biomarker for ototoxicity-induced hair cell damage: a high-throughput drug development platform targeting hearing loss. Translational research. 166(5). 440–450. 30 indexed citations

Jacob, Abraham, et al.. (2015). The Solid Component of Radiographically Non-Growing, Post-Radiated Vestibular Schwannoma Retains Proliferative Capacity. Annals of Otology Rhinology & Laryngology. 124(10). 834–840. 5 indexed citations

10.

Igarashi, Suzu, et al.. (2014). A Novel High‐Throughput Ototoxicity Assay in Zebrafish: Platform for Drug Development Targeting Hearing Loss. Otolaryngology. 151(S1). 1 indexed citations

11.

Miller, Craig, Suzu Igarashi, & Abraham Jacob. (2012). Molecular Pathogenesis of Vestibular Schwannomas: Insights for the Development of Novel Medical Therapies. Otolaryngologia Polska. 66(2). 84–95. 4 indexed citations

12.

Li, Tao, Liqun Bai, Jing Li, Suzu Igarashi, & Fayez K. Ghishan. (2008). Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene. Gastroenterology. 134(7). 1994–2003. 17 indexed citations

13.

Lai, Li‐Wen, et al.. (2007). A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury. Kidney International. 71(12). 1223–1231. 63 indexed citations

14.

Lien, Yeong‐Hau H., et al.. (2006). S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney International. 69(9). 1601–1608. 115 indexed citations

15.

Erickson, Ann L., Yoichi Kimura, Suzu Igarashi, et al.. (2001). The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes. Immunity. 15(6). 883–895. 321 indexed citations breakdown →

16.

Messier, Helen, et al.. (1993). p70 lupus autoantigen binds the enhancer of the T-cell receptor beta-chain gene.. Proceedings of the National Academy of Sciences. 90(7). 2685–2689. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact